Please click on the links below to access the press releases:
- Merit Medical Acquires Assets of Vascular Insights®, LLC- December 17th 2018
- Vascular Insights® Announces New Chief Executive Officer and President James (Chip) Draper to Lead the Executive Team- October 30th 2018
- Vascular Insights® Announces A New Lead To The Global Commercial Team – March 15th 2018
- National Institute for Health and Care Excellence (NICE) issues approval via Interventional Procedure Guidance IPG557 for endovenous mechanochemical ablation for varicose veins in the United Kingdom – July 13th 2016
- ClariVein® Workshop Offered in Hong Kong at the Asian Society for Vascular Surgery (ASVS)- September 1st 2014
- Vascular Insights Announces New VP of Operations – April 7th 2014
- Vascular Insights Announces Move to Massachusetts – February 4th 2014
- Vascular Insights Announces Vice President of Marketing – January 6th 2014
- Vascular Insights Announces New Chief Executive Officer – September 2nd 2013
- Professor A H Davies, Imperial College London clinical trial comparing ClariVein® with VNUS ClosureFAST– September 2012
- Professor C Wittens, MD, Maastricht University, The Netherlands ClariVein® Dose finding Trial – August 2012
- M Reijnen, MD, Rijnstate Hospital, The Netherlands clinical trial comparing ClariVein® with VNUS ClosureFAST – August 2012
- S Elias, MD, Vascular News – Mechanochemical ablation shows 96% closure rate at two Years– June 2012
- R Bernstein, MD, treatment of defiant venous ulcers with ClariVein® – March 2012
